Study Stopped
the program couldn't be implemented
Radiation Oncology Mobile Application
γ-App
1 other identifier
observational
N/A
1 country
1
Brief Summary
To develop a novel a mobile phone application (available on Android and IOS) for patients receiving radiation treatment for head and neck cancer. Through this application, patients will get access to their treatment calender, through a system connected with Mosiac database, which provides a timely and precise access to their treatments schedule. In addition, patients will be able to report their treatment related toxicity in real time fashion, these symptoms will be addressed daily instead of the weekly floor clinic checks. Furthermore, the radiation oncologist will receive an instant notification through the application, if there is error in patient's treatment (missing field, wrong dose, etc..)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 12, 2018
CompletedFirst Posted
Study publicly available on registry
October 16, 2018
CompletedStudy Start
First participant enrolled
February 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2021
CompletedMay 27, 2022
May 1, 2022
2.7 years
October 12, 2018
May 25, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Grade of symptoms improved with early intervention.
using CTCAE v.5
only during RT (7WEEKS)
Secondary Outcomes (1)
compliance on the mobile.
Only during RT (7WEEKS)
Study Arms (1)
head and neck radiotherapy patients
(Single arm); Patients receiving radiotherapy for head and neck cancers can report their symptoms through the mobile app.
Eligibility Criteria
Patients referred to our radiation oncology clinic with head and neck cancer.
You may qualify if:
- Adult patients receiving definitive or adjuvant RT to head and neck site Chemotherapy is allowed PS:0-1 Has a smart phone
You may not qualify if:
- Poor performance early laryngeal cancer Patient with metastatic disease, or palliative intent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King Hussein Cancer Center
Amman, 11941, Jordan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Radiation Oncology
Study Record Dates
First Submitted
October 12, 2018
First Posted
October 16, 2018
Study Start
February 1, 2019
Primary Completion
October 20, 2021
Study Completion
October 20, 2021
Last Updated
May 27, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share